Clinical trial
Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft…
NCT00148109 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00148109 |
|---|---|
| Title | Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas |
| Official title | Phase II Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Collaborators | Bristol-Myers Squibb Industry Eli Lilly and Company |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | Cetuximab |
| Enrollment | 36 |
| Start date | Jun 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Sep 7, 2005 |
| Last update posted | Jan 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: